Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics Analysis

4 Dec 2023

Abstract excerpt

Secreted phosphoprotein-1 (SPP1) expression is differentially altered in many malignancies and could serve as a potential prognostic biomarker. Recent findings indicated that SPP1 possesses a broader role in bladder cancer (BC) pathogenesis than previously envisioned; however, the underlying mechanisms governing its expression, cellular localization, prognostic value and immune-related role in bladder cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Esophageal Cancer Research and Treatment
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38067407
DOI: 10.3390/cancers15235704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics AnalysisPMID 38067407Read ↗

SPP1 is expected to be a biomarker for predicting prognosis and immunotherapy efficacy in penile cancer patientsSemantic proximity Read ↗

SPP1 is a Prognostic Related Biomarker and Correlated with Tumor-Infiltrating Immune Cells in Hepatocellular CarcinomaSemantic proximity Read ↗

A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancersSemantic proximity Read ↗

A Pan-Cancer Study: The Immunological and Prognostic Significance of Aberrant SPP1 Expression on TumorsSemantic proximity Read ↗

Identification of plasma secreted phosphoprotein 1 as a novel biomarker for upper tract urothelial carcinomasSemantic proximity Read ↗

SPP1 Might Be a Novel Prognostic Biomarker for Patients With Malignancy: a Meta-analysis and Sequential Verification Based on Bioinformatic AnalysisSemantic proximity Read ↗

SPP1 Might Be A Novel Prognostic Biomarker For Patients With Malignancy: A Meta-Analysis And Sequential Verification Based on Bioinformatic AnalysisSemantic proximity Read ↗

SPP1 is a Prognostic Related Biomarker and Correlated With Tumor-Infiltrating Immune Cells in Ovarian CancerSemantic proximity Read ↗

The Significance of Secreted Phosphoprotein 1 in Multiple Human CancersSemantic proximity Read ↗

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancerSemantic proximity Read ↗

The oncogenic functions of SPARCL1 in bladder cancerSemantic proximity Read ↗

Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.